Evaluating the skin in patients undergoing chimeric antigen receptor modified T-cell therapy

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2016-11, Vol.75 (5), p.1054-1057
Main Authors: Rubin, Courtney B., MD, Elenitsas, Rosalie, MD, Taylor, Laura, MD, Lacey, Simon F., PhD, Kulikovskaya, Irina, MSc, MB(ASCP)CM, Gupta, Minnal, MSc, Melenhorst, Jan J., PhD, Loren, Alison, MD, MS, Frey, Noelle, MD, MSCE, June, Carl H., MD, Porter, David, MD, Rosenbach, Misha, MD
Format: Article
Language:English
Subjects:
Adult
Aged
Antigens, CD19
Blood Transfusion, Autologous - adverse effects
CD3 Complex - genetics
CD3 Complex - immunology
Cytokines - secretion
Dermatology
Hematologic Neoplasms - therapy
Humans
Immunotherapy - adverse effects
Immunotherapy - methods
Lymphocyte Transfusion - adverse effects
Male
Middle Aged
Neoplasms, Second Primary - diagnosis
Neoplasms, Second Primary - etiology
Neoplasms, Second Primary - immunology
Protein Domains
Receptors, Antigen, T-Cell - genetics
Receptors, Antigen, T-Cell - immunology
Recombinant Fusion Proteins - genetics
Recombinant Fusion Proteins - immunology
Skin Diseases - diagnosis
Skin Diseases - etiology
Skin Diseases - immunology
Skin Neoplasms - diagnosis
Skin Neoplasms - etiology
Skin Neoplasms - immunology
Syndrome
T-Lymphocytes, Cytotoxic - immunology
T-Lymphocytes, Cytotoxic - transplantation
Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics
Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2016.06.062